Project Indication Mechanism Preclinical IND Phase I Phase II
MAX-1 Solid Tumor IO
MAX-2 Solid Tumor IO
MAX-3 Auto Immune Targeted
MAX-4-A AML Targeted
MAX-4-S Solid Tumor Targeted
MAX-5 AML+CLL Targeted
MAX-6 Solid Tumor Targeted
MAX-7 Confidential Confidential Licensed Out
CONTACT US
Please leave us a message,
we will reply to you as soon as possible, thank you!
MAX-1
Indication: Solid Tumor Mechanism: IO
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-2
Indication: Solid Tumor Mechanism: IO
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-3
Indication: Auto Immune Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-4-A
Indication: AML Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-4-S
Indication: Solid Tumor Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-5
Indication: AML+CLL Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-6
Indication: Solid Tumor Mechanism: Targeted
  • Preclinical
  • IND
  • Phase I
  • Phase ll
MAX-7
Indication: Confidential Mechanism: Confidential
  • Preclinical
  • IND
  • Phase I
  • Phase ll
  • Licensed Out